Terbutaline: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "1 mg" to "1mg") |
Neil.m.young (talk | contribs) (Text replacement - "4 mg" to "4mg") |
||
| Line 12: | Line 12: | ||
===Asthma/Bronchoconstriction=== | ===Asthma/Bronchoconstriction=== | ||
*0.005-0.01mg/kg to max 0. | *0.005-0.01mg/kg to max 0.4mg SQ q15-20 min, up to 3 doses; may repeat in 2-6 hours | ||
==Special Populations== | ==Special Populations== | ||
Revision as of 09:50, 26 July 2016
General
- Type: Beta 2 agonist
- Dosage Forms: 1mg/mL injection
Adult Dosing
Preterm labor
- 0.25mg sq q20-30 min, up to 4 doses PRN contractions
Asthma/Bronchoconstriction
- 0.25mg sq q20 min, up to 3 doses
Pediatric Dosing
Asthma/Bronchoconstriction
- 0.005-0.01mg/kg to max 0.4mg SQ q15-20 min, up to 3 doses; may repeat in 2-6 hours
Special Populations
- Pregnancy Rating: Category C
- Lactation: Not recommended
- Renal Dosing: n/a
- Hepatic Dosing: n/a
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Black box warning against prolonged use for tocolysis (>48-72 hrs)
- Cardiac arrhythmia
Common
- Agitation, tremor, hyperglycemia, hypokalemia
Pharmacology
- Onset: 6-15 minutes
- Half-life: 11-16 hours
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action: Beta 2 agonist, smooth muscle relaxant
See Also
References
Lexicomp